REFERENCES
- Najmabadi H, Karimi-Nejad R, Sahebjam S, . The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25(3):285–296.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
- Newton CR, Graham A, Heptinstall LE, . Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989;17(7):2503–2516.
- Old JM, Khan SN, Verma I, . A multi-center study in order to further define the molecular basis of β-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. Hemoglobin. 2001;25(4):397–407.
- Farhud DD, Sadighi H. Investigation prevalence of β thalassemia in Iranian provinces. Iranian J Public Health. 1997;26(1–2):3–6.
- Najmabadi H, Pourfathollah AA, Neishaburay M, Sahebjam F, Krugluger W. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002;87(10):1113–1114.
- Orkin SH, Old JM, Weatherall DJ, Nathan DG. Partial deletion of β-globin gene DNA in certain patients with β0-thalassemia. Proc Natl Acid Sci USA. 1979;76(5):2400–2404.
- Habibi-Rudknar M, Najmabadi H, Derakhshandeh P, Farhud DD. Detection of rare and unknown mutations in β-thalassemia traits in Iran. Iranian J Public Health. 2003;32(1):11–14.
- Khan SN, Riazuddin S. Molecular characterization of β-thalassemia in Pakistan. Hemoglobin. 1998;22(4):333–345.
- Agrawal MG, Bhanushali AA, Dehia P, . Compound heterozygosity of Hb D(Iran) β22 Glu→Gln and β0-thalassemia (619 bp deletion) in India. Eur J Haematol. 2007;79(3):248–250.